Diabetes Pill Controversy Shows Rift in FDA Ranks

By: Matthew Perrone AP Email
By: Matthew Perrone AP Email

WASHINGTON (AP) - The diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?

It's the type of crucial safety question that the agency was established to answer. But as the FDA began a two-day meeting Tuesday to determine Avandia's fate, it became clear that the agency's own scientists are divided.

On Wednesday the FDA will ask a panel of advisers to untangle the mess of data that has stumped its own scientists for over three years.

The group will vote on recommendations, including possible withdrawal of the drug. The FDA will make a final decision in coming months.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 98363399